Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients
Top Cited Papers
Open Access
- 2 November 2011
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 306 (17) , 1891-1901
- https://doi.org/10.1001/jama.2011.1592
Abstract
Solid organ transplantation provides life-saving therapy for patients with end-stage organ disease. In 2010, a total of 28 664 transplants were performed in the United States, including 16 899 kidney transplants, 6291 liver transplants, 2333 heart transplants, and 1770 lung transplants.1 Although transplant outcomes have improved dramatically over time, substantial morbidity results from chronic immunosuppressive therapy administered to prevent graft rejection.Keywords
This publication has 36 references indexed in Scilit:
- Risk factors for early‐onset and late‐onset post‐transplant lymphoproliferative disorder in kidney recipients in the United StatesAmerican Journal of Hematology, 2010
- PRO- AND ANTI-CANCER EFFECTS OF IMMUNOSUPPRESSIVE AGENTS USED IN ORGAN TRANSPLANTATIONTransplantation, 2004
- Cancer after Kidney Transplantation in the United StatesAmerican Journal of Transplantation, 2004
- Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study ReportAmerican Journal of Transplantation, 2004
- Cancer risk following organ transplantation: a nationwide cohort study in SwedenBritish Journal of Cancer, 2003
- Posttransplantation Lymphoproliferative DisordersArchives of internal medicine (1960), 2003
- Identifying the patient at risk for post‐transplant lymphoproliferative disorderTransplant Infectious Disease, 2001
- Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation.2000
- Cancer incidence in a kidney-transplanted populationTransplant International, 2000
- Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the futureAmerican Journal of Kidney Diseases, 2000